The average CSF p-tau/Aβ 1–42 ratio in AD was significantly higher than in controls, DLB, and DLB with AD (controls, p < .001; DLB, p = .002; DLB with AD, p = .041) (Fig 2F). Here, MAPT is linked to Alzheimer disease.